Drugmaker Retrophin Sues Ex-CEO For $65M
Biopharmaceutical company Retrophin Inc. on Monday sued its founder and former CEO in New York federal court for $65 million, alleging that he breached his loyalty to the company when using...To view the full article, register now.
Already a subscriber? Click here to view full article